Published in Blood Weekly, April 13th, 1998
The production of tissue-engineered blood vessels (TEBVs) has required synthetic or modified biological materials for structural support.
Nicholas L'Heureux, Hopital du Saint-Sacrement, Quebec, Canada, and colleagues reported a novel approach to TEBV production which uses no synthetic or exogenous biomaterials, but rather is based solely on the use of cultured cells ("A Completely Biological Tissue-Engineered Human Blood Vessel," FASEB Journal, 1998;12:47-56).
L'Heureux et al. said their results suggest that their technique can produce completely biological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.